Trials / Terminated
TerminatedNCT00765570
Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy
Treatment of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy A Phase II Randomized Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Summa Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Expand clinical literature on the use of Grid radiation with conventional external beam therapy. Vast majority of therapy is for palliative care to provide relief from pain, but has also shown a reduction in the size of tumor mass.
Detailed description
This study will evaluate response to radiation therapy by a large bulky tumor is influenced by adding a single dose of 15 Gy grid radiotherapy. To accomplish this, patients with large bulky tumors in the lung, abdomen or pelvis will be randomized to receive either standard palliative radiation or palliative radiation plus a single fraction of grid radiation. Tumor response, pain relief and duration of response, and pain control will be monitored. Toxicity of treatment will also be followed. The hypothesis of this study is that grid radiation will produce a significant improvement in tumor response and pain control that produces no further increase in acute or late toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Spatially Fractioned Radiation Therapy | evaluate response to radiation therapy by a large bulky tumor influenced by adding a single dose of 15 Gy grid radiotherapy. |
| RADIATION | Treatment Group 1 | one treatment of Grid therapy followed by 15 treatments with standard radiation |
| RADIATION | Standard radiation | 15 Standard radiation treatments |
| RADIATION | Standard radiation | standard radiation treatment |
Timeline
- Start date
- 2003-02-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2008-10-03
- Last updated
- 2015-05-18
- Results posted
- 2015-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00765570. Inclusion in this directory is not an endorsement.